Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623037 | SCV000741464 | pathogenic | Inborn genetic diseases | 2016-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001040018 | SCV001203570 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2022-06-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 521051). This variant has not been reported in the literature in individuals affected with CRB1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu1058*) in the CRB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CRB1 are known to be pathogenic (PMID: 10508521, 22065545, 23379534, 25412400, 26957898, 28041643, 29391521). |
Genome- |
RCV003451477 | SCV004180132 | pathogenic | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451476 | SCV004180133 | pathogenic | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003451477 | SCV005058547 | pathogenic | Leber congenital amaurosis 8 | 2024-03-13 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000678549 | SCV000804628 | pathogenic | Stargardt disease | 2016-09-01 | no assertion criteria provided | clinical testing |